Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07310745) titled 'Low Dose Radiotherapy in Primary Indolent Cutaneous B-cell Lymphoma' on Dec. 16, 2025.

Study Type: Observational

Primary Sponsor: Azienda USL Reggio Emilia - IRCCS

Condition: Primary Indolent Cutaneous B-cell Lymphoma

Recruitment Status: Not recruiting

Date of First Enrollment: January 2026

Target Sample Size: 90

Countries of Recruitment: Italy

To know more, visit https://clinicaltrials.gov/study/NCT07310745

Disclaimer: Curated by HT Syndication....